P. Joseph Campisi

Joseph serves as Senior Vice President and General Counsel, bringing to Turnstone more than 30 years of experience in mergers and acquisitions, collaborations, and securities offerings and corporate governance. Joseph joined Turnstone from Scorpion Therapeutics where he was Executive Vice President, General Counsel and Secretary. Prior to this, Joseph was Senior Vice President and Deputy General Counsel at Bristol-Myers Squibb (“BMS”), where he oversaw the Transactional Practice Group of the BMS Law Department. During more than 16 years at BMS, Joseph was responsible for the completion of over 100 strategic transactions, including the sale of BMS Medical Imaging, the divestiture of the BMS diabetes business, the sale of ConvaTec, and the initial public offering and subsequent split-off of Mead Johnson Nutrition, as well as the acquisitions of Medarex, Inc. and Celgene Corporation. Before BMS, Joseph was a partner at the law firm Pillsbury Winthrop Shaw Pitman LLP, where he was a member of the firm’s Corporate and Securities and Life Sciences practice groups, and spent time in the firm’s offices in New York, London, Hong Kong and San Francisco during his 13-year tenure there. Joseph obtained a Juris Doctor with distinction from Hofstra University School of Law, a Master of Business Administration (Finance), and a Bachelor of Science (Accounting) from St. John’s University. He is admitted to the bar in both the State of New York and the State of California and is licensed in the State of New York as a Certified Public Accountant (inactive).